Circulating autoantibodies have been recognized as disease biomarkers of autoimmune diseases. We have previously disclosed a synthetic glycopeptide that is able to detect specific autoantibodies in sera of patients who are affected by multiple sclerosis (MS). This glycopeptide is characterized by a type I′ beta-turn around the minimal epitope Asn(Glc) that allows an efficient exposure of this moiety to antibody interactions in the context of a solid-phase immunoenzymatic assay. With the aim of optimizing the glycopeptide-antibody interactions, we analyze a series of new glycopeptides based on different turn structures. Our results confirm the role of conformation in the recognition and binding of synthetic antigenic probes to MS autoantibodies. Glycopeptide 2, which is characterized by a type I beta-turn around the minimal epitope Asn(Glc), shows the highest antibody affinity (IC50 ) 11.8 nM), and thus it appears to be a promising tool for the detection of specific autoantibodies as MS biomarker in patients’ sera.

Designed glycopeptides with different beta-turn types as synthetic probes for the detection of autoantibodies, biomarkers of Multiple Sclerosis / A. Carotenuto; M. Alcaro; M. Saviello; E. Peroni; F. Nuti; A. Papini; E. Novellino; P. Rovero. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 51:(2008), pp. 5304-5309. [10.1021/jm800391y]

Designed glycopeptides with different beta-turn types as synthetic probes for the detection of autoantibodies, biomarkers of Multiple Sclerosis

M. Alcaro;E. Peroni;F. Nuti;PAPINI, ANNA MARIA;ROVERO, PAOLO
2008

Abstract

Circulating autoantibodies have been recognized as disease biomarkers of autoimmune diseases. We have previously disclosed a synthetic glycopeptide that is able to detect specific autoantibodies in sera of patients who are affected by multiple sclerosis (MS). This glycopeptide is characterized by a type I′ beta-turn around the minimal epitope Asn(Glc) that allows an efficient exposure of this moiety to antibody interactions in the context of a solid-phase immunoenzymatic assay. With the aim of optimizing the glycopeptide-antibody interactions, we analyze a series of new glycopeptides based on different turn structures. Our results confirm the role of conformation in the recognition and binding of synthetic antigenic probes to MS autoantibodies. Glycopeptide 2, which is characterized by a type I beta-turn around the minimal epitope Asn(Glc), shows the highest antibody affinity (IC50 ) 11.8 nM), and thus it appears to be a promising tool for the detection of specific autoantibodies as MS biomarker in patients’ sera.
2008
51
5304
5309
A. Carotenuto; M. Alcaro; M. Saviello; E. Peroni; F. Nuti; A. Papini; E. Novellino; P. Rovero
File in questo prodotto:
File Dimensione Formato  
Carotenuto-jmc_2008.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Tutti i diritti riservati
Dimensione 928.28 kB
Formato Adobe PDF
928.28 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/351101
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 30
social impact